IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Advertising in In Vivo

Letter from the Managing Editor

Dear Advertiser :

IN VIVO is a multidisciplinary peer-reviewed journal designed to bring together original high quality works on experimental and clinical biomedical research.
A special focus of the journal is the rapid publication of works advancing the application of results of experimental research in the diagnosis and therapy of human diseases.
IN VIVO is addressed to all scientists working in the following fields: oncology, pharmacology, chemotherapy, biotherapy, immunology, radiology, toxicology, genetics, cytology, endocrinology, pathology, nutrition, development, biotechnology.
We are pleased to invite your Company to contribute advertisements for rapid publication in IN VIVO.
Please feel free to contact us for further information and with any queries that you may have.

Sincerely

G. J. Delinasios
Managing Editor


Exchange Of Advertisements

An Invitation to Publishers

Advertisements of books and journals are welcome for immediate publication in IN VIVO following an agreement for a mutually beneficial exchange. Submitted advertisements should fulfil the instructions for advertising in IN VIVO.


Further information: Any queries concerning advertising should be addressed to: IN VIVO Editorial Office, International Institute of Anticancer Research, 1st km Kapandritiou-Kalamou Rd., Kapandriti, P.O.B. 22, Attiki 19014, Greece. Tel & Fax: 0030-22950-53389.
e-mail:journals@iiar-anticancer.org

or

US branch: ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
e-mail: journals@iiar-anticancer.org


  • 1987 – 2019
  • 33 volumes
  • over 27,000 pages
  • over 4,100 original articles and reviews
  • over 27,800 authors
  • conference abstracts
  • special issues
  • author – subject indexes
  • open access articles
  • included in Pubmed and most abstracting services
  • online with HighWire Press

IMPORTANT NOTE: You may submit your article only through our online submission system